On Nov 05, 2025, STAA reported earnings of 0.18 USD per share (EPS) for Q3 25, beating the estimate of 0.16 USD, resulting in a 9.29% surprise. Revenue reached 94.73 million, compared to an expected 92.64 million, with a 2.26% difference. The market reacted with a +5.47% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of 0.06 USD, with revenue projected to reach 77.42 million USD, implying an decrease of -66.67% EPS, and decrease of -18.27% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
CONMED Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$1.34
Actual
$1.43
Surprise
+5.94%
Pro-Dex Inc New
Report Date
Jan 29, 2026 For Q2 26
Estimate
$0.60
Actual
$0.66
Surprise
+9.67%
FAQ
What were Staar Surgical Co's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Staar Surgical Co reported EPS of $0.18, beating estimates by 9.29%, and revenue of $94.73M, 2.26% above expectations.
How did the market react to Staar Surgical Co's Q3 2025 earnings?
The stock price moved up 5.47%, changed from $25.25 before the earnings release to $26.63 the day after.
When is Staar Surgical Co expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for Staar Surgical Co's next earnings report?
Based on 11
analysts, Staar Surgical Co is expected to report EPS of $0.06 and revenue of $77.42M for Q4 2025.